cap
structur
distinct
featur
eukaryot
mrna
import
rna
stabil
protein
translat
provid
molecular
signatur
distinct
self
nonself
mrna
eukaryot
virus
gener
modifi
end
rna
mimic
cellular
mrna
structur
therebi
facilit
viral
replic
host
cell
howev
molecular
organ
biochem
mechan
viral
cap
apparatu
typic
differ
cellular
counterpart
make
viral
cap
enzym
attract
target
drug
discoveri
previou
work
show
sar
coronaviru
sarscov
nonstructur
protein
repres
structur
novel
uniqu
abl
function
complement
yeast
cellular
present
studi
develop
yeastbas
system
identifi
screen
inhibitor
coronaviru
use
microtit
plate
mtase
inhibitor
previous
identifi
vitro
biochem
assay
test
sinefungin
effect
suppress
yeast
system
howev
compound
ata
adohci
exert
inhibitori
effect
within
cellular
context
result
valid
yeast
assay
system
inhibitor
screen
yet
also
demonstr
differ
cellbas
vitro
biochem
assay
yeast
system
appli
screen
natur
product
extract
three
observ
potent
inhibit
activ
coronaviru
human
cellular
messeng
rna
mrna
higher
eukaryot
mani
viral
rna
sequenti
methyl
posit
guanosin
cap
cap
structur
sever
import
biolog
role
protect
mrna
degrad
exoribonucleas
schwer
et
al
direct
premrna
splice
mrna
export
nucleu
darnel
addit
cap
structur
confer
stabil
mrna
ensur
effici
recognit
translat
initi
factor
translat
filipowicz
et
al
schibler
perri
contrast
host
viru
rna
molecul
unprotect
end
degrad
cytoplasm
compart
liu
kiledjian
uncap
rna
nascent
viral
transcript
may
also
detect
nonself
rna
sensor
rigi
ifit
host
cell
abba
et
al
bowzard
et
al
hornung
et
al
zust
et
al
trigger
antivir
innat
immun
respons
product
interferon
ifit
interferoninduc
protein
mediat
antivir
activ
daffi
et
al
nallagatla
et
al
rehwinkel
et
al
follow
four
capform
enzym
involv
format
structur
rna
triphosphatas
hydrolyz
triphosph
nascent
premrna
diphosph
ii
rna
guanylyltransferas
cap
diphosph
rna
gmp
iii
rna
methyl
gpppn
cap
posit
guanin
result
structur
shuman
iv
ribos
omtas
methyl
first
nucleotid
higher
eukaryot
cellular
viral
mrna
ribos
oh
posit
form
structur
furuichi
shatkin
omtas
util
sadenosyllmethionin
adomet
methyl
http
elsevi
bv
right
reserv
abbrevi
sar
sever
acut
respiratori
syndrom
sarscov
sar
coronaviru
nsp
nonstructur
protein
omtas
omethyltransferas
adomet
sadenosyllmethionin
adohci
sadenosyllhomocystein
ata
aurintricarboxyl
acid
ic
inhibitori
concentr
activ
donor
gener
sadenosyllhomocystein
adohci
byproduct
eukaryot
virus
replic
cytoplasm
encod
cap
apparatu
structur
mechan
viral
rna
cap
apparatu
differ
host
cell
furuichi
shatkin
could
use
develop
antivir
drug
inde
number
biochem
function
studi
previous
address
methyltransferas
potenti
inhibitor
target
chrebet
et
al
schwer
et
al
woyciniuk
et
al
moreov
enzym
involv
coronaviru
cap
pathway
increasingli
consid
promis
target
potenti
anticoronaviru
drug
coronavirus
cov
infect
mani
speci
anim
includ
human
caus
acut
chronic
respiratori
diseas
eg
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
de
groot
et
al
zaki
et
al
infecti
bronchiti
viru
ibv
enter
diseas
eg
transmiss
gastroenter
viru
tgev
central
nervou
system
cn
diseas
murin
hepat
viru
mhv
weiss
navasmartin
cov
largest
rna
virus
envelop
contain
singlestrand
positivesens
rna
genom
rang
kb
length
genom
sarscov
contain
open
read
frame
orf
snijder
et
al
gener
nonstructur
protein
nsp
produc
autocatalyt
process
polyprotein
viral
proteas
ziebuhr
et
al
cov
replic
host
cytoplasm
encod
cap
enzym
among
four
cap
enzym
involv
coronaviru
format
identifi
previou
work
use
yeast
genet
system
chen
et
al
omethyltransferas
omtas
form
cofactor
chang
et
al
chen
et
al
decroli
et
al
lugari
et
al
sarscoronaviru
previous
character
exoribonucleas
exon
chen
et
al
minskaia
et
al
domain
map
carboxytermin
part
protein
chen
et
al
interestingli
exon
activ
site
dispens
though
exon
domain
requir
activ
combin
two
function
domain
chen
et
al
chen
et
al
uniqu
featur
among
indic
sarscov
novel
form
rnaprocess
enzym
thu
suggest
attract
target
develop
antivir
drug
shown
cap
function
yeast
cell
replac
capform
enzym
mammal
dna
virus
ho
et
al
saha
et
al
saha
et
al
previous
found
coronaviru
could
replac
yeast
cap
vivo
chen
et
al
chen
et
al
present
studi
develop
yeast
genet
system
highthroughput
enzymat
activ
assay
platform
variou
identifi
coronaviru
inhibitor
system
valid
use
mtase
inhibitor
previous
identifi
vitro
biochem
assay
use
screen
natur
product
extract
code
sequenc
nonstructur
protein
sarscov
mhv
tgev
ibv
pcr
amplifi
cdna
sarscov
whu
strain
genbank
access
hussain
et
al
genbank
access
tgev
genbank
access
ibv
genbank
access
insert
bamhi
xhoi
site
yeast
vector
lm
chen
et
al
cdna
merscov
chemic
synthes
accord
deposit
sequenc
merscov
genbank
access
clone
express
e
coli
cell
code
sequenc
sar
mhv
insert
ndei
sali
site
tgev
kindli
provid
dr
lui
enjuan
clone
bamhi
sali
site
plasmid
ibv
express
kind
gift
dr
eric
j
snijder
e
coli
cell
novagen
separ
transform
plasmid
cell
cultur
l
lb
medium
supplement
kanamycin
lgml
ampicillin
lgml
cultur
densiti
reach
induc
mm
iptg
h
cell
harvest
recombin
protein
purifi
affin
chromatographi
use
previous
describ
protocol
chen
et
al
protein
concentr
ultrafiltr
millipor
buffer
chang
mm
trishcl
ph
mm
nacl
glycerol
mm
dtt
protein
store
use
activ
assay
carri
reaction
mixtur
mm
trishcl
ph
mm
mgcl
mm
dtt
unit
rnase
inhibitor
mm
sam
lci
sadenosyl
h
methionin
cimmol
mciml
purifi
coronaviru
protein
ad
final
concentr
nm
use
mm
gpppa
cap
analog
substrat
incub
h
reaction
stop
ad
equal
volum
stop
solut
sd
mm
edta
sampl
purifi
use
deaesephadex
column
methyl
rna
substrat
quantit
count
per
minut
cpm
use
scintil
counter
beckman
coulter
ls
measur
inhibitori
effect
coronavir
activ
adohci
aurintricarboxyl
acid
ata
ribavirin
sinefungin
use
maximum
concentr
lm
assay
typic
enzym
gpppa
substrat
preincub
compound
room
temperatur
rt
min
reaction
initi
addit
sadenosyl
h
methionin
control
reaction
perform
presenc
dmso
instead
test
compound
ic
concentr
drug
repress
activ
valu
sinefungin
sarscov
determin
use
graphpad
data
adjust
logist
doserespons
function
yeast
gene
shown
essenti
yeast
cell
growth
mao
et
al
saccharomyc
cerevisia
strain
mata
mao
et
al
transform
yeast
express
plasmid
carri
coronaviru
human
posit
control
chen
et
al
saha
et
al
trp
transform
select
agar
medium
lack
tryptophan
cell
streak
onto
agar
medium
lack
tryptophan
contain
mgml
acid
sikorski
boek
day
counterselect
plasmid
carri
yeast
gene
format
foaresist
coloni
indic
transform
mutant
could
replac
complement
endogen
cap
function
resid
plasmid
chen
et
al
chen
et
al
solut
sinefungin
adenosylornithin
calbiochem
ribavirin
sigma
adohci
adenosinehomocystein
sigma
prepar
h
dmso
decroli
et
al
luzhkov
et
al
milani
et
al
ata
aurintricarboxyl
acid
sigma
dissolv
mm
naoh
decroli
et
al
concentr
stock
solut
set
mm
compound
store
microtit
plate
plate
use
yeast
growth
suppress
test
inhibitor
screen
singl
transform
coloni
strain
contain
plasmid
express
human
mthuman
sarscov
mtsar
coronavirus
mtmhv
mttgev
mtibv
vector
control
repres
yeast
mtyeast
inocul
separ
ml
basic
medium
min
sd
base
lack
tryptophan
incub
h
reach
similar
final
cell
densiti
stationari
phase
cellsml
chrebet
et
al
start
cell
densiti
yeastbas
assay
contain
differ
inhibitor
candid
dmso
neg
control
highthroughput
screen
lgml
lgml
natur
product
extract
ad
microtit
plate
start
volum
microtit
plate
respect
final
cell
densiti
measur
use
multifunct
micropl
reader
tecan
genio
incub
h
shaker
incub
yeast
cell
collect
ground
liquid
nitrogen
total
rna
isol
cell
use
trizol
reagent
invitrogen
subject
realtim
pcr
analysi
measur
mrna
express
realtim
pcr
perform
use
faststart
univers
sybr
green
mastermix
roch
analyz
real
time
pcr
system
appli
biosystem
genespecif
primer
sequenc
follow
mtsar
forward
revers
aatc
mthuman
forward
revers
atc
mtyeast
forward
revers
betaactin
forward
revers
cggaag
microbi
natur
product
extract
obtain
microbi
natur
product
librari
hubei
biopesticid
engin
research
centr
hberc
consist
purifi
secondari
metabolit
semipurifi
fraction
extract
actinomycet
fungi
isol
soil
lichen
fresh
leav
organ
sampl
mushroom
use
classic
isol
method
soil
lichen
mg
quantifi
place
tube
contain
ml
steril
sodium
lauryl
sulfat
solut
shaken
min
sampl
seed
asept
chop
small
piec
use
blender
sampl
plate
two
differ
agar
media
incub
day
actinomyc
fungi
isol
pure
cultur
incub
microbi
isol
morpholog
character
store
archiv
ratio
actinomycetesfungi
collect
microorgan
hberc
around
microbi
ident
character
classic
molecular
methodolog
activ
compound
identifi
correspond
microbi
extract
prepar
microbi
extract
microbi
isol
ferment
ml
ferment
medium
result
cultur
extract
ethyl
acet
make
work
solut
microbi
extract
extract
dissolv
ethanol
concentr
mgml
wv
total
microbi
cultur
extract
use
mtase
inhibitor
screen
studi
prepar
actinomycet
fungi
previou
studi
show
sarscov
possess
activ
could
substitut
cellular
yeast
chen
et
al
chen
et
al
system
gene
encod
yeast
knock
yeast
genom
complement
express
plasmid
select
marker
result
yeast
strain
wherea
exogen
express
anoth
plasmid
trp
select
marker
express
function
gene
encod
monophosph
decarboxylas
result
convers
nontox
compound
toxic
yeast
medium
contain
counterselect
cell
yeast
cell
grow
normal
exogen
protein
replac
function
cellular
fig
studi
confirm
sarscov
human
could
rescu
growth
yeast
cell
defici
test
whether
activ
univers
coronavirus
shown
fig
coronavirus
includ
tgev
group
mhv
group
sarscov
group
merscov
group
ibv
group
show
activ
function
vivo
complement
endogen
yeast
enzym
result
indic
well
conserv
among
differ
coronavirus
appear
target
develop
univers
inhibitor
coronavirus
gener
three
yeast
strain
grew
depend
activ
sarscov
mtsar
human
mthuman
yeast
mtyeast
compar
express
level
analyz
mrna
level
use
realtim
pcr
shown
fig
signific
differ
mrna
level
mtsar
mthuman
control
yeast
promot
mrna
mtyeast
transform
vector
control
similar
yeast
train
mrna
yeast
transcrib
complementari
plasmid
bear
yeastmt
strain
mtsar
mthuman
express
yeast
could
detect
data
shown
express
mtsar
mthuman
similar
level
yeast
strain
could
use
identifi
inhibitor
inhibit
sarscov
mtase
potent
human
mtase
howev
mrna
level
mtsar
mthuman
four
time
higher
mtyeast
latter
express
lowcopynumb
plasmid
centromer
element
cen
inhibitori
activ
sarscov
yeast
mtase
directli
compar
establish
drug
screen
system
use
yeast
strain
first
test
whether
express
viral
human
influenc
yeast
growth
individu
coloni
mtyeast
mthuman
mtsar
cultur
medium
lack
tryptophan
precultur
dilut
fresh
medium
aliquot
cultur
incub
well
two
plate
one
use
measur
yeast
propag
spectrophotometri
wherea
plate
use
direct
count
cell
number
measur
perform
interv
h
shown
fig
e
three
yeast
strain
mtsar
mthuman
mtyeast
show
similar
growth
curv
within
h
indic
sarscov
human
mtase
could
support
normal
growth
yeast
cell
growth
condit
start
liquid
cultur
time
period
h
correspond
logarithm
growth
phase
fig
e
growth
phase
optic
densiti
well
correl
cell
number
demonstr
yeast
strain
mtsar
linear
regress
analysi
fig
linear
regress
equat
r
r
regress
coeffici
show
correl
cultur
liquid
cell
number
logarithm
phase
h
mtsar
least
squar
method
use
evalu
interrelationship
two
variabl
x
x
repres
spectrophotometr
measur
repres
correspond
cell
number
logarithm
phase
h
mtsar
linear
regress
equat
mtsar
strain
r
r
regress
coeffici
obtain
norm
analysi
least
squar
method
excel
program
linear
regress
equat
correl
cultur
liquid
cell
number
logarithm
phase
h
mtsar
r
r
similarli
also
high
correl
two
optic
absorb
cell
number
strain
mtyeast
mthuman
linear
regress
equat
r
r
respect
spectrophotometr
measur
facilit
rapid
highthroughput
evalu
microtit
plate
optic
densiti
cell
cultur
appli
measur
yeast
growth
ensu
experi
valid
yeastbas
system
identifi
screen
inhibitor
viral
test
previous
report
mtase
inhibitor
includ
adohci
sinefungin
aurintricarboxyl
acid
ata
ribavirin
first
detect
activ
coronavirus
vitro
incub
differ
compound
lm
use
biochem
assay
shown
fig
sinefungin
effect
inhibit
activ
four
adohci
ata
weakli
inhibit
activ
sar
mhv
tgev
approxim
inhibit
lm
except
ibv
inhibit
contrast
ribavirin
guanosin
ribonucl
analog
use
interfer
viral
rna
synthesi
viral
mrna
cap
mani
differ
virus
kim
lee
scholtissek
zhao
et
al
inhibit
coronaviru
doserespons
curv
sinefungin
best
inhibitor
three
effect
compound
show
ic
valu
sinefungin
sarscov
nm
fig
sinefungin
could
wide
inhibit
activ
mtase
divers
sourc
includ
virus
yeast
exampl
ic
valu
sinefungin
omtas
vaccinia
viru
vitro
nm
respect
pugh
et
al
ic
valu
omtas
activ
dengu
viru
vitro
nm
li
et
al
nm
ic
valu
sinefungin
yeast
nm
vivo
chrebet
et
al
nm
vitro
zheng
et
al
respect
report
previous
ic
valu
adohci
mm
omtas
activ
vaccinia
viru
vitro
respect
pugh
borchardt
studi
inhibitori
effect
sinefungin
adohci
ata
mtase
consist
previou
report
sinefungin
adohci
ata
effect
inhibitor
coronavirus
biochem
assay
use
valid
yeastbas
assay
system
establish
studi
fig
yeast
strain
mtyeast
mthuman
mtsar
incub
lm
compound
cell
growth
measur
interv
period
remark
sinefungin
significantli
repress
growth
three
yeast
strain
fig
confirm
previou
report
sinefungin
potent
inhibitor
chrebet
et
al
li
et
al
pugh
et
al
contrast
ata
adohci
ribavirin
exhibit
inhibitori
activ
three
yeast
strain
adohci
ata
could
inhibit
activ
coronaviru
biochem
assay
result
show
clear
differ
vitro
biochem
assay
vivo
cellbas
assay
indic
inhibitor
identifi
use
vitro
biochem
assay
may
necessarili
effect
within
cellular
context
discrep
may
attribut
low
membran
permeabl
adohci
ata
ic
adohci
ata
far
greater
lm
inde
sinefungin
report
activ
transport
across
yeast
membran
whilst
adohci
ata
zheng
et
al
zheng
et
al
sinefungin
produc
streptomyc
natur
sulfurmodifi
analog
adohci
wellcharacter
nonspecif
mtase
inhibitor
shown
fig
sinefungin
exhibit
similar
inhibitori
effect
three
yeast
strain
high
concentr
lm
howev
stronger
inhibitori
effect
mtyeast
observ
mthuman
strain
harbor
mtase
coronavirus
low
concentr
lm
fig
b
could
explain
intrins
differ
inhibitori
effect
differ
mtase
differ
express
level
mtase
show
higher
mrna
level
mthuman
mtase
coronavirus
express
mtyeast
fig
character
sinefungin
mtase
inhibitor
yeastbas
system
yeast
strain
express
differ
incub
sinefungin
differ
concentr
h
fig
ic
n
mean
valu
sd
mtyeast
mthuman
mtase
coronavirus
calcul
shown
tabl
result
indic
sinefungin
broadspectrum
inhibitor
variou
speci
includ
yeast
human
coronavirus
demonstr
yeastbas
system
could
use
analysi
inhibitor
howev
sinefungin
ideal
antivir
inhibitor
due
lack
specif
coronaviru
compar
yeast
human
mtase
therefor
still
necessari
screen
specif
viral
inhibitor
effort
benefit
function
studi
viral
mtase
clinic
drug
develop
screen
effect
microbi
natur
product
use
yeastbas
assay
three
yeast
strain
mtyeast
mthuman
mtsar
genet
background
growth
depend
yeast
human
sarscov
mtase
respect
yeastbas
system
describ
adopt
screen
specif
inhibitor
coronaviru
note
mrna
level
mtsar
mthuman
similar
higher
mtyeast
fig
howev
would
influenc
screen
inhibitor
specif
inhibit
sarscov
mtase
human
mtase
screen
inhibitor
sarscov
microbi
natur
product
extract
test
yeastbas
system
microbi
extract
prepar
liquid
cultur
actinomycet
fungi
describ
materi
method
section
overnight
cultur
mtyeast
mthuman
mtsar
dilut
aliquot
cell
cultur
seed
microtit
plate
presenc
lgml
microbi
natur
product
extract
twenti
hour
postincub
cell
densiti
monitor
measur
optic
densiti
first
round
extract
repress
mthuman
select
test
primari
candid
extract
test
twice
reproduc
inhibitori
effect
use
independ
sampl
extract
summari
obtain
three
candid
extract
natur
product
extract
fungu
speci
preliminarili
character
penicillium
spp
natur
product
extract
actinomycet
preliminarili
character
streptomyc
spp
could
potent
inhibit
growth
mtsar
mtyeast
significantli
less
effect
inhibit
mthuman
fig
inhibit
ratio
extract
mtsar
mthuman
respect
contrast
sinefungin
suppress
growth
yeast
strain
final
concentr
lm
lgml
fungal
actinomyc
natur
product
extract
use
studi
compos
complex
ingredi
three
extract
could
use
isol
activ
ingredi
futur
work
taken
togeth
yeastbas
assay
system
could
provid
platform
screen
inhibitor
effect
viral
mtase
less
effect
human
mtase
effici
drug
develop
often
depend
highthroughput
screen
offer
rapid
sensit
data
acquisit
coupl
highcont
analys
explor
possibl
miniatur
yeastbas
assay
increas
throughput
scale
yeast
cell
seed
microtit
plate
growth
mtsar
yeast
cell
monitor
interv
h
shaker
fig
b
logarithm
growth
phase
h
optic
densiti
cultur
well
correl
cell
number
fig
follow
linear
regress
equat
establish
mtsar
strain
r
indic
correl
microtit
plate
microtit
plate
fig
valid
yeastbas
system
highthroughput
screen
inhibitor
perform
growth
suppress
assay
measur
ic
sinefungin
yeast
strain
test
format
fig
e
ic
valu
n
mean
valu
sd
sinefungin
mtyeast
mthuman
mtsar
mtmhv
mttgev
mtibv
nm
nm
nm
nm
nm
nm
respect
tabl
highli
consist
microtit
plate
fig
tabl
result
indic
yeastbas
highthroughput
screen
system
could
use
discoveri
specif
antivir
inhibitor
comparison
micropl
assay
assay
system
reliabl
cost
effect
mani
coronavirus
caus
sever
human
anim
diseas
recent
novel
sarslik
coronaviru
middl
east
respiratori
syndrom
coronaviru
merscov
belong
genu
betacoronaviru
identifi
saudi
arabia
subsequ
spread
unit
kingdom
uk
germani
franc
altawfiq
lim
et
al
wiwanitkit
clinic
approv
antivir
therapi
includ
effect
antivir
drug
avail
date
treatment
coronavirusassoci
diseas
establish
highthroughput
antivir
inhibitor
screen
system
import
develop
novel
anticoronaviru
drug
number
repres
mean
standard
deviat
sd
n
fig
inhibitori
effect
microbi
natur
product
extract
screen
use
yeastbas
system
sinefungin
inhibitor
use
posit
control
yeast
cultur
absenc
extract
compound
use
mock
control
repres
three
microbi
natur
product
extract
growth
suppress
percentag
calcul
x
x
x
valu
mock
cultur
valu
presenc
sinefungin
microbi
natur
product
extract
experi
repeat
three
time
result
shown
percent
suppress
cell
growth
yeast
strain
mtsar
mthuman
mtyeast
although
adohci
ata
sinefungin
previous
report
inhibitor
coronaviru
rna
mtase
vitro
sinefungin
significantli
suppress
growth
mtyeast
mthuman
mtsar
yeast
cell
fig
among
three
strain
sinefungin
effect
mtyeast
mtsar
fig
thu
observ
differ
vitro
biochem
assay
yeastbas
assay
indic
inhibitor
identifi
vitro
biochem
assay
may
effect
cell
yeast
cellbas
assay
system
similar
host
cell
regard
complex
chemic
composit
vitro
biochem
assay
former
may
advantag
latter
identif
antivir
inhibitor
function
effect
live
cell
although
yeastbas
assay
system
valid
test
previous
identifi
inhibitor
specif
inhibitor
coronaviru
identifi
yeastbas
system
develop
studi
includ
three
yeast
strain
carri
yeast
human
coronaviru
activ
method
could
use
screen
identifi
inhibitor
specif
coronavirus
significantli
less
effect
human
addit
structur
mechanist
differ
among
coronaviru
yeast
human
mtase
also
provid
rational
develop
specif
inhibitor
accordingli
exploit
differ
screen
natur
product
extract
interestingli
three
extract
show
potent
inhibitori
effect
sarscov
yeast
human
fig
use
drug
screen
system
abl
oper
highthroughput
manner
therefor
yeast
cellbas
system
studi
optim
microtit
plate
system
yeast
cell
grew
well
sediment
fig
current
adomet
adohci
backbon
use
synthes
analog
develop
inhibitor
specif
viral
lim
et
al
highthroughput
yeastbas
platform
make
possibl
screen
larg
number
natur
product
extract
yeastbas
system
use
screen
chemic
synthes
compound
librari
compound
obtain
screen
may
contribut
drug
design
develop
need
control
coronavirus
